Merck KGaA (OTCMKTS:MKKGY) Short Interest Down 75.0% in December

Merck KGaA (OTCMKTS:MKKGYGet Free Report) was the recipient of a large drop in short interest in December. As of December 15th, there was short interest totalling 400 shares, a drop of 75.0% from the November 30th total of 1,600 shares. Based on an average trading volume of 280,200 shares, the short-interest ratio is presently 0.0 days.

Analyst Ratings Changes

Separately, The Goldman Sachs Group initiated coverage on shares of Merck KGaA in a report on Thursday, September 19th. They issued a “buy” rating on the stock.

Read Our Latest Stock Analysis on Merck KGaA

Merck KGaA Stock Down 0.1 %

Merck KGaA stock traded down $0.02 during mid-day trading on Friday, reaching $29.08. 121,440 shares of the company were exchanged, compared to its average volume of 75,991. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.91 and a current ratio of 1.33. The firm has a market cap of $18.79 billion, a P/E ratio of 17.95, a PEG ratio of 2.32 and a beta of 0.93. Merck KGaA has a 12-month low of $28.29 and a 12-month high of $39.17. The business has a fifty day moving average of $30.85 and a 200 day moving average of $33.87.

About Merck KGaA

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Further Reading

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.